According to the International Testing Agency (ITA), Lasconi Mulamba - who participated in the 100 meters sprint, after having the sample being collected out-of-competition.
Stanozolol is a very commonly used substance in track and field. Out of the 3300 sanctioned track and field athletes we have registered in the Anti-Doping Database, more than 300 of them tested positive for Stanozolol.
The most famous athlete who tested positive for the steroid was the Canadian Ben Johnson at the Seoul Olympic Games in 1988.
The case of Lasconi Mulamba is the fifth doping case during the Olympic Games in Paris. At the Tokyo Olympic Games the International Testing Agency asserted six anti-doping rule violations.
The International Testing Agency (ITA) reports that a sample collected from athlete Lasconi Mulamba from the Democratic Republic of Congo (Athletics - 100m sprint) has returned an Adverse Analytical Finding for the non-specified prohibited substance stanozolol metabolite (classified as S1. Anabolic Androgenic Steroid according to the Prohibited List of the World Anti-Doping Agency (WADA)).
The sample was collected by the ITA under the testing authority and results management authority of the International Olympic Committee (IOC) during an out-of-competition anti-doping control on 4 August 2024 in Paris, France. The result was reported by the WADA-accredited laboratory of Paris on 9 August 2024.
The athlete has been informed of the case and has been provisionally suspended until the resolution of the matter in line with the World Anti-Doping Code and the IOC Anti-Doping Rules applicable to the Olympic Games Paris 2024. This means that the athlete is prevented from competing, training, coaching, or participating in any activity, during the Olympic Summer Games Paris 2024.
The athlete has the right to challenge the imposition of the provisional suspension before the Court of Arbitration for Sport – Anti-Doping Division (CAS ADD).
The athlete also has the right to request the analysis of the B-sample.